Sage Therapeutics: Q1 Earnings Insights

Comments
Loading...

 

Sage Therapeutics SAGE reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Sage Therapeutics missed estimated earnings by 1.47%, reporting an EPS of $-2.07 versus an estimate of $-2.04.

Revenue was down $1.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 5.59% increase in the share price the next day.

Here's a look at Sage Therapeutics's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -2.17 -1.85 -1.69 -1.91
EPS Actual -2.12 -2.21 -1.83 -1.64
Revenue Estimate 1.97M 1.96M 2.01M 2.00M
Revenue Actual 1.64M 1.44M 1.64M 1.58M

To track all earnings releases for Sage Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!